Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,654,276
-
Share change
-
-846,870
-
Total reported value
-
$5,144,557
-
Put/Call ratio
-
101%
-
Price per share
-
$3.11
-
Number of holders
-
23
-
Value change
-
-$2,149,681
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q1 2021
As of 31 Mar 2021,
ACER THERAPEUTICS INC - COM (ACER) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,654,276 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BlackRock Inc., Squarepoint Ops LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, TWO SIGMA ADVISERS, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.